ÂÜÀòÂÒÂ×

Ron Shmueli is a seasoned professional in formulation science, currently serving as a Principal Scientist at Vertex Pharmaceuticals since January 2023. Prior experience includes roles as Senior Scientist and Scientist II in formulation at Synlogic, Inc. from June 2018 to December 2022, as well as serving as a Scientist in Pharmaceutical Sciences at Catabasis Pharmaceuticals, Inc. between August 2016 and May 2018. At Catabasis, Ron was the Formulation Lead, responsible for developing novel formulations, generating analytical data, supporting animal studies, and contributing to IND filings. Importantly, Ron has a strong background in academia, including postdoctoral positions at The Johns Hopkins University and AsclepiX Therapeutics, along with a Ph.D. in Biomedical Engineering from The Johns Hopkins University and a Bachelor's degree in Chemical Engineering from Columbia University.